Executives from Boehringer Ingelheim, Carnot Laboratorios, Bayer and AstraZeneca outlined the investments at President Claudia Sheinbaum’s morning press conference.

Boehringer Ingelheim targets production of 5 billion pills per year in CDMX

Boehringer Ingelheim, a German company, intends to invest 3.5 billion pesos ($187.2 million) in Mexico in the coming years. Juan Augusto Muench Castañeda, the company’s general director in Mexico, said that the outlay will go toward making Boehringer Ingelheim’s tablet production plant in Mexico City “the [company’s] largest in the world.”

Carnot to open new plant in Hidalgo

“Today with a lot of enthusiasm and a lot of confidence in Mexico, we would like to announce the expansion and global positioning of Carnot Laboratorios,” said CEO Edmundo Jiménez Luna. He said that the Mexican company will invest 3.5 billion pesos over the next five years, money that “will generate 600 highly specialized direct jobs and at least 5,000 indirect ones.” Jiménez said that the investment will go to a new production plant in Villa de Tezontepec, a municipality in the state of Hidalgo.

Bayer to invest 3 billion pesos over 5 years

Manuel Bravo Pereyra, CEO of Bayer in Mexico, said that the company will invest 3 billion pesos over the next five years. In addition, Bravo said that Bayer, a German multinational, will triple its investment in clinical studies in Mexico. “This will allow Mexicans to have access to the most innovative medications more quickly,” he said.

AstraZeneca to invest 2.25 billion pesos over 2 years

Julio Ordaz, CEO of British-Swedish company AstraZeneca in Mexico, said that the company is investing 2.25 billion pesos in Mexico over two years to the end of 2026. He said that more than 1.4 billion pesos will go to “clinical research” in Mexico, while funds will also be used to expand AstraZeneca’s Global Innovation and Technology Center, located in the metropolitan area of Guadalajara, Jalisco. In addition, part of the company’s investment will go to the expansion of its medication production plant in Naucalpan, México state.